Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Belsky Marc Create: Alert

All | News | Filings
Date FiledTypeDescription
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 195,000 options to buy @ $6.84, valued at $1.3M
01/07/2022 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 140,000 options to buy @ $14.55, valued at $2M
01/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2020 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Bought 15,384 shares @ $2.6, valued at $40k
01/13/2020 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 90,000 options to buy @ $3.29, valued at $296.1k
11/13/2019 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Bought 800 shares @ $2.7588, valued at $2.2k
09/10/2019 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 60,000 options to buy @ $3.38, valued at $202.8k
08/21/2019 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Bought 200 shares @ $4.42, valued at $884
08/12/2019 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Bought 500 shares @ $4.82, valued at $2.4k
07/26/2019 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Bought 444 shares @ $5.654, valued at $2.5k
Bought 56 shares @ $5.8, valued at $324.8
01/08/2019 4 Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 60,000 options to buy @ $22.85, valued at $1.4M
02/28/2018 4 Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
Txns: Granted 3,000 shares @ $0
Granted 18,000 options to buy @ $18.69, valued at $336.4k
02/07/2018 4 Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
Txns: Paid exercise price by delivering 1,048 shares @ $18.42, valued at $19.3k
09/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/09/2017 4 Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
01/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
09/01/2016 4 Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
08/29/2016 4 Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
04/26/2016 4 Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
04/08/2016 4 Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
03/31/2016 4 Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC
10/15/2009 4 Belsky Marc (VP Finance & CAO) has filed a Form 4 on CELL GENESYS INC
Txns: Disposed/sold 6,456 @ $0
Disposed/sold 55,000 @ $1.84, valued at $101.2k
Disposed/sold 50,000 @ $3.8, valued at $190k
08/01/2008 4 Belsky Marc (VP Finance and CAO) has filed a Form 4 on CELL GENESYS INC
Txns: Paid exercise price by delivering 3,664 @ $3.105, valued at $11.4k
02/08/2008 4 Belsky Marc (VP Finance and CAO) has filed a Form 4 on CELL GENESYS INC
Txns: Granted 55,000 @ $1.84, valued at $101.2k
08/01/2007 4 Belsky Marc (VP Finance and CAO) has filed a Form 4 on CELL GENESYS INC
Txns: Granted 10,120 @ $0
12/05/2006 4 Belsky Marc (VP Finance and CAO) has filed a Form 4 on CELL GENESYS INC
Txns: Granted 50,000 @ $3.8, valued at $190k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy